|
By Emma Hitt, PhD
In August of 2001 some cancer patients in Kansas
City had to worry that their cancer drugs were not as strong as
they should have been. Missouri pharmacist Robert Courtney admitted
to diluting the chemotherapy of at least 30 cancer patients; officials
estimate that the number may have been more than 150.
Suspicions arose when a pharmaceutical sales representative noticed
that Courtneys pharmacy had purchased only about one third
of the amount of a drug it had supposedly provided and billed to
patients.
Samples from the pharmacy tested at an independent lab were found
to be highly diluted. The case a rarity highlighted
the importance of the pharmacists role in patient care
especially cancer patients.
Although many well-trained pharmacists work solely with cancer patients
there are about 300 pharmacists in the United States who have taken
the rigorous test required to become board-certified oncology pharmacists
(BCOPs).
According to Barry R. Goldspiel PharmD at the National
Institutes of Health Bethesda Maryland pharmacists
specializing in oncology are especially knowledgeable about ways
to handle the toxicities associated with many cancer drugs. They
are also well versed in the interactions between herbal medications
and chemotherapy and are aware of important resources for cancer
patients.
The oncology pharmacist assists oncology physicians and nurses
by providing supportive care to the patient including antiemetic
[nausea] and pain management says Betsy Althaus
PharmD BCOP Senior Pharmacist at the University of California
San Francisco Comprehensive Cancer Center.
Not all patients need extra help in these areas but
if a patient is having uncontrolled pain or nausea the pharmacist
is called upon to help develop a regimen that is tailored to the
patients needs Althaus says. They then follow
the patient over time and in consultation with the team
adjust medications as needed.
Most major hospitals have pharmacists who specialize in oncology
which in part helps make sure there are no errors in
dosing since chemotherapy dosing errors could be deadly
says William D. Figg PharmD a pharmacology researcher
at the National Cancer Institute Bethesda Maryland.
Althaus says that because of the toxicity associated with chemotherapy
oncology pharmacists must make several checks when they fill an
order. The selection of chemotherapy drugs must match the disease;
the ordered regimen must match the standard published regimen; the
physicians calculations must be double-checked; the patients
lab work must be checked to make sure it is safe for them to receive
the chemotherapy; antiemetic medicines must be checked to ensure
they are strong enough to prevent nausea.
Every pharmacist double-checks prescriptions and drug orders
Althaus says but the difference for the oncology pharmacist
is the complexity of cancer and the drugs used to treat it.
|